Introduction
Non-Hodgkin's lymphomas (NHLs) account for about 85% of lymphomas with others being Hodgkin's lymphomas. NHLs are a highly heterogeneous group with around 40 existent forms, in spite of a few common types predominating. 1 NHL is the fifth most common cancer in the UK, which occurs either in lymph nodes and other lymphatic tissues, such as the tonsils, spleen, Waldeyer's ring, and thymus, or the lymphatic cells of other organs. 2 With the increasing aging population and immunodeficiency states, the incidence of it increases and seems to be more than doubled in the past 30 years.
Forskolin is reported to have the potential to directly activate the adenylate cyclase enzyme, which induces the production of cyclic adenosine monophosphate (cAMP) from ATP, leading to the increase of intracellular cAMP. 8 Notably, cAMP has been identified to affect multiple cellular functions and is closely associated with tumorigenesis through protein kinase A-dependent/independent manner, including inhibition of the viability and migration and enhancement of the chemosensitivity of cancer cells. [9] [10] [11] [12] Its analog 8-CPT-cAMP [8-(4-chlorophenylthio) adenosine 3′, 5′-cyclic monophosphate] has been documented to promote apoptosis of lymphoma cells. 13 Importantly, forskolin, the cAMP-elevating agent, exerts anticancer roles in many kinds of cancers, and also improves the chemosensitivity of conventional drugs. [14] [15] [16] However, the effects of forskolin in NHL remain unclarified.
Many signaling transduction pathways are reported to be deregulated and strongly implicated in the occurrence and development of multiple kinds of cancers, including Hippo/ Yes-associated protein (YAP), 17 Wnt/β-catenin, 18 phosphatidylinositol 3-hydroxy kinase/AKT, 19 signal transduction and transcriptional activator (STAT), 20 and P53. 21 As a result, we performed the current study to explore the effects of forskolin in the progression of NHL, and determine if these signaling pathways are involved in it.
Materials and methods

Cell culture and treatment
NHL cell lines Toledo, NK-92, RL, and Farage were all purchased from American Type Culture Collection (VA, USA). Toledo, Farage, and RL cells were cultured in RPMI-1640 medium containing 10% FBS (Gibco, CA, USA); NK-92 cells were cultured in Alpha Minimum Essential Medium with ribonucleosides and deoxyribonucleosides free while with 2 mM L-glutamine and 1.5 g/L sodium bicarbonate, 0.2 mM inositol, 0.1 mM 2-mercaptoethanol, 0.02 mM folic acid, 100-200 U/mL recombinant IL-2, 12.5% horse serum (Sigma-Aldrich Co., St Louis, MO, USA), and 12.5% FBS.
Toledo or NK-92 cells were incubated with different concentrations of forskolin (0, 10, 20, 40, 80, or 160 µM; cAMP analog 8-pCPT-2′-OMe-cAMP; Sigma-Aldrich Co) for the indicated times, and 20 µM of SP600125 (Selleck Chemicals, Shanghai, China), an inhibitor of c-Jun N-terminal kinase (JNK) for 24 hours.
Cell transfection
Small interference (si) RNA targeting human Axin (No. SR305433, Origene, CA, USA) was used to downregulate the expression of Axin in Toledo and NK-92 cells using Lipofectamine 2000 (Thermo Fisher Scientific, Waltham, MA, USA).
Lentivirus with puromycin resistance and green fluorescent protein label containing human β-catenin gene was purchased from GenePharma (OE-β-catenin; Shanghai, China) and was used to upregulate the expression of β-catenin in either Toledo cells or NK-92 cells.
Western blotting analysis
Total protein of cells was extracted with cold RIPA buffer (Solarbio, Beijing, China), and cytoplasmic and nucleoprotein were obtained by CelLytic ™ NuCLEAR ™ Extraction Kit (Thermo Fisher Scientific, Waltham, MA, USA). For Western blotting analysis, 20 µg of protein obtained from cultured cells with protein lysis buffer was separated by 10% SDS-PAGE and then transferred to polyvinylidene difluoride (PVDF) porous membrane (Thermo Fisher Scientific). After incubated with 5% nonfat milk diluted with TBST to protect the antibody from nonspecific binding, the PVDF membrane was incubated with the indicated primary and the corresponding secondary antibodies successively. Finally, the membranes were incubated with ECL Chemiluminescent regent (Millipore, Darmstadt, Germany) and Meta Morph software was used to quantify the Western blotting bands after background subtraction. Primary antibodies used in this study are listed in Table S1 . Histone, tubulin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were used to normalize the expression of nuclear protein cytoplasmic protein and total protein, respectively.
immunoprecipitation (iP) assay
For IP assay, the cells were rinsed with cold PBS and lysed in IP lysis buffer (Thermo Fisher Scientific). Then the cell lysate containing 200 µg proteins was precleared with Dynabeads ® protein G for 1 hour, and incubated with 2 µg of antibody against Axin or β-catenin overnight at 4°C, and then incubated with Dynabeads ® protein G for an additional 1 hour of incubation. The beads were washed four times with IP lysis buffer and loaded onto gels using anti-Ub antibody.
Real time PCR (RT-PCR) analysis
Total RNA from cells and tissue samples were extracted with an RNAsimple Total RNA Kit (TIANGEN, Beijing, China). After quantification, 1 µg RNA from every sample was transcribed reversely into the first strand cDNA using (forward: 5′-CGACTTGCTGGACTTCTGGT-3′ and  reverse: 5′-ATATGCCCTTCCCTGTCCCT-3′) and GAPDH  (forward: 5′-TCTTTTGCGTCGCCAGCC-3′ and reverse: 5′-GTTCTCAGCCTTGACGGTGC-3′).
MTT assay
Toledo and NK-92 cells were seeded in a 96-well plate with 5×10 3 cells/well and grown in a medium containing 10% FBS for 24 hours, then they were treated with 0, 10, 20, 40, 80, and 160 µM forskolin for 1, 2, 3, 4, 5, and 6 days. After the indicated time points, cell medium was discarded and 20 µL 5 mg/mL of MTT solution was added and incubated for another 4 hours at 37°C. Then, 100 µL dimethyl sulfoxide solution (Sigma-Aldrich Co, MO, USA) was added to dissolve the insoluble formazan crystals after the medium get rid of each well. The OD values were measured at 570 nm on a plate reader (Multiskan GO, Thermo Fisher Scientific). 
Flow cytometry assay
in vivo tumorigenesis assay
Male 18-20 g BALB/c nude mice were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). The mice were fed in specific pathogen-free conditions on a 12-hour light/dark cycle with standard food and water available. For tumor formation assay, Toledo and NK-92 cells were infected with OE-NC or OE-β-catenin, followed by screening with puromycin to construct stable cell lines, then 5×10 6 stable transfected Toledo and NK-92 cells were subcutaneously injected into nude mice, with 24 mice in each group. Then, mice infected with OE-NCor OE-β-catenin-expressing cells were divided into four groups, respectively: control, forskolin, SP600125, forskolin + SP600125 groups or OE-β-catenin, OE-β-catenin + forskolin, OE-β-catenin + SP600125, OE-β-catenin + forskolin + SP600125 groups. Forskolin (10 mg/kg) or SP600125 (30 mg/kg) was injected to the mice every 7 days when the tumors were grown 3-4 mm in diameter and were visible. All mice were euthanized after 28 days of the implantation, then the tumors of each mouse were taken out for weighing or for immunohistochemical staining. All protocols involving animals were in accordance with the Animal Experiment Ethics Review of Ethics Committee of Henan Kaifeng Children Hospital University and this study was approved by Ethics Committee of Henan Kaifeng Children Hospital.
immunohistochemistry Formalin-fixed paraffin-embedded cancer tissue samples were cut into 5 µm sections. After deparaffinized, hydrated, and blocked with 5% of goat serum (AmyJet Scientific, Inc., Wuhan, China), the sections were probed with the primary antibody against Ki-67 (No. 12202, Cell Signaling Technology, CA, USA) and the corresponding second antibody (Cell Signaling Technology), followed by incubation with the chromogen 3, 30-diaminobenzidine tetrachloride (R&D Systems, Inc., Minneapolis, MN, USA). Cell nucleus was stained with Harri's hematoxylin solution.
Data analysis
All experiments in this study were performed at least three times. Data were expressed as mean ± SD and were statistically analyzed with SPSS software (version 23.0) using Student's t-test. A difference with a P-value <0.05 was regarded as statistically significant. To explore the underlying mechanism of forskolin, we assessed the expression of proteins related to key signaling pathways regulating cell fate, such as Hippo/YAP, Wnt/β-catenin, AKT, JNK/STAT, and P53 in the presence of 40 µM forskolin. Results showed that the expression of β-catenin was reduced when Toledo and NK-92 cells were treated with 40 µM of forskolin for 48 hours, while the expression of other proteins p-AKT, AKT, p-STAT, STAT, and P53 showed no apparent change (Figure 2A , B). The expression of ubiquitin was also increased in the presence of forskolin as compared to the control group in both Toledo and NK-92 cells ( Figure 2C ). Besides, the nuclear protein of β-catenin was decreased while cytoplasmic β-catenin protein was increased after cells were treated with forskolin in a concentration-dependent manner both in Toledo ( Figure 3A) and NK-92 cells ( Figure 3B ). Moreover, forskolin decreased the expression of oncogenic proteins cyclin D1 and c-myc, downstream proteins of β-catenin signaling ( Figure 3C , D). These results suggest that forskolin represses the activation of β-catenin signaling pathway.
Results
Forskolin induces nhl cell apoptosis
Forskolin reduces the expression of β-catenin via upregulating axin expression in nhl cells
Next, we explored the expression of proteins related to β-catenin signaling, including Frz, Axin, glycogen synthase kinase 3β (GSK-3β), adenomatous polyposis coli (APC), and CK1. Results showed that only the expression of Axin was upregulated when Todelo and NK-92 cells were treated with 40 µM forskolin ( Figure 4A , B), suggesting that Axin upregulation might induce the downregulation of β-catenin under forskolin treatment. Then, we specifically investigated 
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Wang et al and cytoplasmic β-catenin increase ( Figure 4F, G) . Besides, forskolin promoted the expression of c-myc protein in a concentration-dependent way ( Figure 5A ). Furthermore, forskolin slowed down the degradation of Axin protein ( Figure  5B -D) and inhibited its ubiquitination ( Figure 5E ). Taken these results together, we clarify that forskolin reduces the expression of β-catenin via upregulating Axin expression in NHL cells.
Forskolin enhances cell apoptosis induced by sP600125 in nhl cells
As shown in Figure 6A , SP600125 increased the expression of cleaved caspase-3/9 in Toledo and NK-92 cells, as compared to the control group ( Figure 6A, B) . Similarly, SP600125 and forskolin increased the apoptosis rate (total early and late apoptosis) of Toledo and NK-92 cells, and cell apoptosis was enhanced when cells were treated with SP600125 and forskolin simultaneously ( Figure 6C ). Besides, SP600125 enhanced the translocation of β-catenin protein from nuclear to cytoplasm ( Figure 6D , E) and reduced the ubiquitination of Axin protein ( Figure 6F ) induced by forskolin treatment in Toledo and NK-92 cells. The results specified above suggest that SP600125 could enhance the effects induced by forskolin in the apoptosis and β-catenin location and Axin stability in NHL cells.
Forskolin/sP600125 represses tumor growth through downregulating β-catenin in vivo
Finally, we explored the function of forskolin/SP600125 in NHL cell tumorigeneis in vivo. Results showed that tumor weights ( Figure 7A ) and the expression of Ki-67 ( Figure  7B ), a proliferative index, were all decreased when NK-92 cells were treated with SP600125, forskolin, or SP600125 + forskolin together, especially for SP600125 + forskolin when compared with the control group. Upregulation of β-catenin significantly enhanced the tumorigenesis of NK-92 cells. And the inhibition of tumorigenesis and Ki-67 expression induced by SP600125, forskolin, or SP600125 + forskolin was repressed when β-catenin was upregulated in NK-92 cells 
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Discussion
Pediatric NHL is characterized by high degree of malignancy, rapid progress, and even invasion into the bone marrow and central nervous system. 22 Although the cure rate of pediatric NHL has reached 70%-90%, some children still have underwent recurrence or death in the short term after chemotherapy even during chemotherapy. 23 Therefore, how to optimize therapy methods to reduce the recurrence rate and additional pain to the minimum has become research hot. This study focuses on this issue and demonstrates that forskolin treatment could significantly promote cell apoptosis and inhibit cell viability through Axin-dependent β-catenin signaling inhibition in NHL. Moreover, forskolin enhances the antitumor role induced by SP600125, which provides theoretical foundation of serving forskolin as a new effective therapeutic drug for pediatric NHL.
Forskolin has been certified to be a valid medication for multiple diseases, including heart disease, diabetes, hypertension, and asthma. 24, 25 Besides, forskolin, an analog of cAMP, which induces cell apoptosis in multiple cancers and overcomes drug resistance, [26] [27] [28] is suggested as one of the most promising molecules for potential application in cancer therapy. 11 For instance, several years ago, Piontek et al 29 reported that forskolin inhibited the proliferation of the gastric cancer cells through reduction of the expression of some oncogenes. Yamanaka et al 30 demonstrated that forskolin inhibited cell proliferation and induced the apoptosis of rhabdomyosarcoma, neuroblastoma, and hepatoblastoma cells through inhibiting Hedgehog signaling pathway and reduced c-myc expression in a dose-dependent manner. They also revealed that forskolin could inhibit human rhabdomyosarcoma xenograft. 31 Interestingly, forskolin was proved to protect the skin from UV injury and UV-induced carcinogenesis and suggested as a latent UV-protective drug in sun-sensitive or melanoma-prone individuals. 32 And the current study explored the function of forskolin in NHL for the first time, and illustrated that forskolin also exerts an anticancer role in NHL, which significantly promoted the apoptosis and inhibited the tumor growth of NHL cells.
Moreover, we investigated the underlying mechanism of forskolin in NHL progression inhibition. We observed that only the expression of β-catenin was obviously decreased, while the expression levels of other signaling-related proteins such as AKT, p-AKT, STAT, p-STAT, P53, and YAP1 showed no significant change. Moreover, forskolin treatment accelerated the transportation of β-catenin protein from nuclear to cytoplasm and increased its ubiquitination. These findings suggest that β-catenin signaling pathway plays a vital role in the anticancer effects induced by forskolin. Wnt/β-catenin signaling pathway controls cell fate and tissue homeostasis, which plays a momentous role in the pathogenesis of many different kinds of disease. 33, 34 On the surface of cells, Wnt 
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Wang et al ligands bind to a receptor complex of two molecules consisting of a member of the Frizzled family and the low-density lipoprotein receptor-related protein family, LRP5/6, then β-catenin will be released from the destruction complex 35, 36 including Axin, APC, GSK-3β, casein kinase 1α, βTrCP1, and βTrCP2, which sequentially mediates a reduction of the phosphorylation and ubiquitination of β-catenin protein.
Then β-catenin accumulates in cell nucleus where it forms a complex with T-cell factor/lymphoid enhancer factor family, which acts as a transcription factor for oncogenic genes such as cyclin D1 and c-myc. 37 And in this study, we demonstrated that forskolin could increase the expression of Axin through slowing down the degradation of Axin protein and reducing its ubiquitination. Moreover, knockdown of Axin abolished the reduction of the expression of β-catenin, c-myc, and cyclin D1 and the cytoplasmic accumulation of β-catenin mediated by forskolin, indicating that forskolin inhibited the activation of β-catenin signaling through upregulation of Axin in NHL cells.
Furthermore, we also observed that forskolin enhanced the anticancer role of SP600125. SP600125, an inhibitor of JNK pathway, exerts an antitumor role in many kinds of cancers. Kim et al 38 reported that SP600125 reduced the drug resistance of breast cancer cells and stomach cancer cells to doxorubicin in vivo and in vitro. Grassi et al 39 indicated that SP600125 had a remarkable anticancer capacity against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways. In this study, we revealed that SP600125 also exerted an antitumor potential in NHL partly through repressing the expression of β-catenin in an Axin-dependent manner.
Conclusion
The current study clarifies that forskolin can inhibit the progression of NHL through Axin-mediated inhibition of β-catenin signaling. Moreover, forskolin improves the effects of SP600125 on cell apoptosis enhancement and tumorigenesis inhibition of NHL cells. These findings provide theoretical foundation of serving forskolin as a new effective therapeutic drug for pediatric NHL.
